Oval Ventures
Venture capitalJapan · Pre-Seed–Seed
Investment thesis
The firm employs a reverse pitching approach, reaching out to entrepreneur candidates to demonstrate potential synergies. It provides venture building support, backing founders through proof of concept stages and assisting with foundational company building. The firm is deeply hands-on, offering strategic guidance, product development support, and hiring assistance as needed.
Source: firm website, verified Jul 21, 2026.
Investments · 6 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does Oval Ventures invest at?
- Oval Ventures invests at the Pre-Seed, Seed stages.
- What sectors does Oval Ventures focus on?
- Oval Ventures focuses on AI & Machine Learning, Deep Tech.
- Where is Oval Ventures located?
- Oval Ventures is headquartered in Japan, JP.
Images
Similar investors
Boundary Capital invests in high-growth private technology companies focused on positive impact across life sciences, AI, and engineering sectors.
Clear Ventures is a Silicon Valley venture capital firm focused on early-stage investing in frontier technology and services. The firm manages $335 million in capital and provides seed funding, strategic connections, and company-building guidance to exceptional startup teams.
Crosscut is an early-stage venture capital firm based in Los Angeles that invests in frontier technologies addressing critical global challenges. The firm focuses on energy transition, decarbonization, space economy, defense systems, advanced manufacturing, robotics, and supply chain reshoring.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Tennr streamlines patient flow in healthcare by automating referral management, insurance verification, clinical context aggregation, and appointment scheduling. The platform processes referrals and intake documentation for approximately 10% of Americans annually.
